You are here

Article Text

Article menu
Download PDFPDF
Industry watch
Tobacco companies introduce ‘tobacco-free’ nicotine pouches
  1. Meagan O. Robichaud1,
  2. Andrew B. Seidenberg2,
  3. M. Justin Byron2,3
  1. 1 Health Sciences, NORC at the University of Chicago, Bethesda, Maryland, USA
  2. 2 Health Behavior, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
  3. 3 Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA
  1. Correspondence to Andrew B. Seidenberg, Health Behavior, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC 27599, USA; aseiden{at}live.unc.edu

https://doi.org/10.1136/tobaccocontrol-2019-055321

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A new product category is emerging with several large tobacco companies now selling ‘tobacco-free’ nicotine pouches. These products are sold as preportioned pouches similar to snus, but instead of containing tobacco leaf, they are filled with white nicotine-containing powder (figure 1). The pouches are placed between the lip and gum, and require no spitting or refrigeration.1 2 At least five large tobacco manufacturers currently sell nicotine pouch products. British American Tobacco sells Lyft in the UK and Sweden,2 3 and Velo (through RJ Reynolds Vapor Company) in the USA.4 Swedish Match sells Zyn in Europe and the USA,5 Kretek International sells Dryft in the USA1 and Japan Tobacco International sells Nordic Spirit in Sweden.6 Moreover, Altria recently agreed to acquire 80% of …

    View Full Text

    Footnotes

    • Contributors MOR led the writing of the manuscript’s first draft. ABS conceptualised the study and helped to draft and revise the manuscript. MJB helped to draft and revise the manuscript.

    • Funding Research reported in this publication was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number F31DA045424. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data availability statement Data are available on request